MiNT Protein: A New Target to Treat Cancer, Diabetes and Other Diseases?

News   Dec 19, 2017 | Original story from Rice University

 
MiNT Protein: A New Target to Treat Cancer, Diabetes and Other Diseases?

An illustration outlines the NEET cycle in cells by which iron-sulfur clusters are delivered by MiNT, mitoNEET (mNT) and NAF-1 proteins in the cytosol or the mitochondria (bottom) to an array of cellular metabolic processes, including the synthesis of ATP. Credit: Illustration by Patricia Jennings/University of California at San Diego

 
 
 

RELATED ARTICLES

Nano and Micro Join Forces to Treat Osteoarthritis

News

There is currently no treatment for curing osteoarthritis, which affects 80% of the population over 75 years of age. But researchers who have been studying the problem have come up with a new treatment that delivers previously-identified active principles directly into the joint in the form of nanocrystals inserted into microparticles.

READ MORE

Machine Learning Helps Predict Schizophrenia Treatment Outcomes

News

New research that used a machine-learning algorithm to investigate MRI images of schizophrenia patients has successfully identified response to antipsychotic treatment in 4 out of 5 patients.

READ MORE

Fragile X: Drug Strategy Could Alleviate Behavioral & Cellular Deficiencies

News

Research in mice shows that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy